DEXPANTHENOL

DEXPANTHENOL was reported 30745 times

DEXPANTHENOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTERIOR SEGMENT ISCHAEMIA 6 0.3158
1 VAGINAL FLATULENCE 42 0.1386
2 PLASMA CELLS INCREASED 10 0.1370
3 SLEEP DISORDER THERAPY 24 0.1212
4 APPENDICOLITH 38 0.0982
5 ANTACID THERAPY 11 0.0846
6 ANALGESIC THERAPY 26 0.0810
7 B SYMPTOMS 2 0.0769
8 PULMONARY VEIN OCCLUSION 6 0.0741
9 DRUG THERAPY 25 0.0737
10 NONALCOHOLIC FATTY LIVER DISEASE 14 0.0714
11 BACTEROIDES INFECTION 16 0.0613
12 ANTHRAX 1 0.0556
13 AQUAGENIC WRINKLING OF PALMS 1 0.0500
14 DEHISCENCE 9 0.0476
15 SALPINGO-OOPHORECTOMY UNILATERAL 5 0.0455
16 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED STAGE IV 2 0.0444
17 HYPOCHOLESTEROLAEMIA 14 0.0397
18 ANTICOAGULANT THERAPY 11 0.0387
19 BLOOD BETA-D-GLUCAN POSITIVE 1 0.0385
20 C-REACTIVE PROTEIN 35 0.0378
21 CONGENITAL HIATUS HERNIA 8 0.0351
22 MALIGNANT MELANOMA STAGE 0 7 0.0335
23 FEMALE GENITAL TRACT FISTULA 50 0.0293
24 FACET JOINT SYNDROME 92 0.0282
25 TRISOMY 18 10 0.0262
26 EPIDERMAL NECROSIS 25 0.0257
27 LEUKAEMIC INFILTRATION PULMONARY 1 0.0217
28 ABDOMINAL INCARCERATED HERNIA 1 0.0200
29 RADICULOPATHY 43 0.0163
30 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 9 0.0160
31 ACUTE ERYTHROID LEUKAEMIA 1 0.0159
32 HYPERPHOSPHATAEMIA 34 0.0158
33 PROCTITIS 42 0.0150
34 NON-ALCOHOLIC FATTY LIVER 5 0.0148
35 LAGOPHTHALMOS 6 0.0147
36 CRITICAL ILLNESS POLYNEUROPATHY 1 0.0145
37 PERIPHERAL VENOUS DISEASE 59 0.0144
38 ACQUIRED PORPHYRIA 1 0.0141
39 CHRONIC SINUSITIS 52 0.0138
40 HEPATIC ENZYME 2 0.0134
41 ALLERGIC TRANSFUSION REACTION 2 0.0132
42 DUODENAL ULCER PERFORATION 95 0.0128
43 BLOOD PHOSPHORUS INCREASED 33 0.0121
44 BREAST CANCER STAGE III 74 0.0114
45 TOTAL LUNG CAPACITY DECREASED 18 0.0113
46 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 10 0.0108
47 HAEMORRHAGIC HEPATIC CYST 1 0.0105
48 MUSCLE INJURY 86 0.0104
49 LUPUS VULGARIS 13 0.0103
50 NEUROLOGICAL INFECTION 1 0.0101
51 OVERLAP SYNDROME 7 0.0100
52 TUMOUR PAIN 13 0.0099
53 LIP DRY 84 0.0092
54 FOETAL MALFORMATION 10 0.0092
55 DISLOCATION OF VERTEBRA 21 0.0092
56 SINUSITIS FUNGAL 7 0.0087
57 ENDOTHELIAL DYSFUNCTION 2 0.0086
58 DEEP VEIN THROMBOSIS POSTOPERATIVE 17 0.0085
59 NAIL DISORDER 73 0.0083
60 HELICOBACTER INFECTION 85 0.0083
61 LIVE BIRTH 69 0.0082
62 KERATITIS HERPETIC 1 0.0082
63 SWOLLEN JOINT COUNT 2 0.0080
64 PEMPHIGUS 100 0.0080
65 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 57 0.0079
66 BLEPHAROSPASM 50 0.0079
67 BURSITIS 96 0.0079
68 IMMUNE-MEDIATED HYPERTHYROIDISM 2 0.0079
69 INJURY CORNEAL 4 0.0077
70 PORPHYRIA ACUTE 11 0.0077
71 BRONCHOMALACIA 1 0.0076
72 RETINITIS 13 0.0075
73 WOUND INFECTION 82 0.0075
74 ONYCHOMADESIS 31 0.0074
75 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 15 0.0072
76 LUNG OPACITY 19 0.0072
77 POUCHITIS 6 0.0070
78 RHEUMATIC FEVER 30 0.0067
79 ENTROPION 1 0.0065
80 ENTEROBACTER PNEUMONIA 1 0.0064
81 AORTIC STENOSIS 22 0.0063
82 C-REACTIVE PROTEIN ABNORMAL 40 0.0062
83 IRON DEFICIENCY 28 0.0062
84 HAND DEFORMITY 81 0.0062
85 RHEUMATOID FACTOR POSITIVE 35 0.0061
86 PERICARDITIS 101 0.0060
87 BLOOD URIC ACID INCREASED 34 0.0059
88 X-RAY ABNORMAL 10 0.0056
89 FOLLICULITIS 58 0.0055
90 PNEUMONIA ASPIRATION 138 0.0055
91 HYPOPHOSPHATAEMIA 39 0.0053
92 CATHETER SITE NODULE 1 0.0052
93 MACROCEPHALY 2 0.0052
94 CRYOPYRIN ASSOCIATED PERIODIC SYNDROME 1 0.0051
95 OBESITY 81 0.0051
96 SWOLLEN JOINT COUNT INCREASED 16 0.0050
97 ACUTE CHOLECYSTITIS NECROTIC 1 0.0050
98 KERATITIS FUNGAL 1 0.0048
99 AUTOINFLAMMATORY DISEASE 1 0.0047
100 RETINAL DEGENERATION 6 0.0046
101 PLASMA CELL MYELOMA REFRACTORY 6 0.0045
102 MYASTHENIA GRAVIS 36 0.0045
103 MUCOCUTANEOUS ULCERATION 1 0.0044
104 OSTEOLYSIS 9 0.0044
105 GRIP STRENGTH 1 0.0044
106 SERONEGATIVE ARTHRITIS 5 0.0044
107 INFUSION SITE REACTION 13 0.0043
108 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 22 0.0043
109 SYSTEMIC INFECTION 7 0.0042
110 NEUTROPENIC INFECTION 4 0.0042
111 VAGINAL DISCHARGE 42 0.0041
112 LIP EROSION 3 0.0041
113 APPENDICITIS 38 0.0041
114 RESPIRATORY SYMPTOM 11 0.0039
115 ESCHERICHIA PYELONEPHRITIS 1 0.0039
116 LEUKAEMOID REACTION 1 0.0038
117 FIBROMYALGIA 93 0.0038
118 CONJUNCTIVITIS VIRAL 1 0.0038
119 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 64 0.0037
120 MACULAR DEGENERATION 44 0.0037
121 BLOOD CHOLINESTERASE DECREASED 1 0.0036
122 LIVER INJURY 87 0.0035
123 THYROXINE FREE DECREASED 2 0.0035
124 HUMAN HERPESVIRUS 6 ENCEPHALITIS 1 0.0035
125 VENTRICULAR FIBRILLATION 38 0.0034
126 CATHETER SITE HAEMATOMA 1 0.0034
127 ORAL CANDIDIASIS 44 0.0033
128 BIOPSY LIVER ABNORMAL 1 0.0033
129 MUCOSAL EROSION 3 0.0033
130 APOPTOSIS 1 0.0032
131 SPUTUM INCREASED 7 0.0032
132 NEPHRITIC SYNDROME 1 0.0032
133 TOXIC EPIDERMAL NECROLYSIS 49 0.0032
134 JOINT DESTRUCTION 5 0.0032
135 BRONCHIAL HAEMORRHAGE 1 0.0032
136 DERMATOSIS 2 0.0032
137 BLOOD CALCIUM INCREASED 28 0.0032
138 PARAESTHESIA ORAL 45 0.0031
139 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 2 0.0031
140 CNS VENTRICULITIS 1 0.0031
141 JOINT RANGE OF MOTION DECREASED 41 0.0031
142 SYNOVITIS 55 0.0030
143 ALOPECIA TOTALIS 1 0.0030
144 CENTRAL NERVOUS SYSTEM INFLAMMATION 1 0.0030
145 BONE MARROW DISORDER 9 0.0030
146 EPILEPSY 90 0.0029
147 GIARDIASIS 1 0.0029
148 CAROTID ARTERY ANEURYSM 1 0.0029
149 FIBROSIS 9 0.0029
150 HYPERCHOLESTEROLAEMIA 28 0.0029
151 COMA 137 0.0029
152 GASTROENTERITIS CLOSTRIDIAL 1 0.0028
153 DRUG TOLERANCE DECREASED 8 0.0028
154 FAECAL OCCULT BLOOD POSITIVE 1 0.0028
155 FUNGAL OESOPHAGITIS 2 0.0028
156 BONE EROSION 10 0.0028
157 OSTEOARTHRITIS 119 0.0028
158 ORTHOSTATIC INTOLERANCE 2 0.0028
159 SYSTEMIC LUPUS ERYTHEMATOSUS 98 0.0028
160 INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT 1 0.0028
161 DIABETIC GASTROPARESIS 1 0.0027
162 CARDIOGENIC SHOCK 38 0.0026
163 ACCELERATED HYPERTENSION 1 0.0026
164 PSORIATIC ARTHROPATHY 106 0.0026
165 LOWER RESPIRATORY TRACT INFECTION 116 0.0025
166 GASTROOESOPHAGEAL REFLUX DISEASE 203 0.0025
167 CATHETER SITE EXTRAVASATION 1 0.0025
168 TROPONIN INCREASED 19 0.0025
169 TYPE 2 DIABETES MELLITUS 84 0.0025
170 DISEASE RISK FACTOR 1 0.0025
171 PLASMA CELL MYELOMA RECURRENT 8 0.0025
172 BACK INJURY 26 0.0024
173 CARDITIS 1 0.0024
174 ALVEOLAR OSTEITIS 1 0.0024
175 TASTE DISORDER 48 0.0024
176 EMBOLISM VENOUS 7 0.0023
177 LENTICULAR OPACITIES 1 0.0023
178 NON-SMALL CELL LUNG CANCER METASTATIC 2 0.0023
179 DIASTOLIC DYSFUNCTION 7 0.0023
180 ALLERGY TO PLANTS 1 0.0022
181 EPIDERMOLYSIS 1 0.0022
182 DYSPHASIA 1 0.0021
183 NEUROLOGICAL EXAMINATION ABNORMAL 1 0.0021
184 PRERENAL FAILURE 3 0.0021
185 APPENDIX DISORDER 3 0.0021
186 IRRITABLE BOWEL SYNDROME 45 0.0021
187 NAIL INFECTION 3 0.0021
188 BACTERIAL INFECTION 39 0.0021
189 TUMOUR MARKER INCREASED 10 0.0021
190 STOMATITIS 126 0.0021
191 WOUND 58 0.0021
192 FREQUENT BOWEL MOVEMENTS 56 0.0021
193 IMMUNODEFICIENCY COMMON VARIABLE 1 0.0020
194 STRABISMUS 6 0.0020
195 BICYTOPENIA 4 0.0020
196 PUSTULAR PSORIASIS 7 0.0020
197 C-REACTIVE PROTEIN INCREASED 72 0.0020
198 CONJUNCTIVAL OEDEMA 2 0.0019
199 GRIP STRENGTH DECREASED 17 0.0019
200 SPONDYLITIS 7 0.0019
201 HYPHAEMA 1 0.0019
202 HEPATIC CIRRHOSIS 36 0.0019
203 IMMUNE-MEDIATED ENCEPHALITIS 1 0.0019
204 HYPERTENSIVE NEPHROPATHY 2 0.0019
205 GLOSSODYNIA 42 0.0019
206 HEART FAILURE WITH REDUCED EJECTION FRACTION 1 0.0019
207 BLOOD CHOLESTEROL INCREASED 87 0.0019
208 INFLAMMATION 96 0.0019
209 PLEURITIC PAIN 5 0.0018
210 STREPTOCOCCAL INFECTION 10 0.0018
211 WHEEZING 106 0.0018
212 CATHETER SITE INFLAMMATION 1 0.0018
213 BREAST CANCER METASTATIC 19 0.0018
214 AUTOIMMUNE DISORDER 17 0.0017
215 FIXED ERUPTION 3 0.0017
216 BENIGN PROSTATIC HYPERPLASIA 9 0.0017
217 BURN ORAL CAVITY 1 0.0017
218 IRON DEFICIENCY ANAEMIA 16 0.0017
219 NIGHT SWEATS 55 0.0017
220 ARTHROPATHY 94 0.0017
221 ADRENAL ADENOMA 1 0.0017
222 FAT NECROSIS 1 0.0016
223 CEREBRAL ASPERGILLOSIS 1 0.0016
224 NASAL POLYPS 8 0.0016
225 ONYCHOMYCOSIS 7 0.0016
226 CORNEAL PERFORATION 1 0.0016
227 METASTASES TO PELVIS 1 0.0016
228 COLITIS 60 0.0016
229 BREAST CANCER STAGE II 13 0.0016
230 BLADDER IRRITATION 1 0.0016
231 PROCEDURAL PAIN 43 0.0015
232 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 10 0.0015
233 ASCITES 45 0.0015
234 MUSCULOSKELETAL PAIN 80 0.0015
235 NEURALGIA 37 0.0015
236 ULCER HAEMORRHAGE 10 0.0015
237 KERATOACANTHOMA 1 0.0015
238 LEIOMYOMA 1 0.0014
239 SWELLING 134 0.0014
240 EXOSTOSIS 13 0.0014
241 BLOOD TEST ABNORMAL 20 0.0014
242 MULTIPLE ORGAN DYSFUNCTION SYNDROME 40 0.0014
243 ESCHERICHIA URINARY TRACT INFECTION 6 0.0014
244 IMPAIRED HEALING 46 0.0014
245 ADRENAL INSUFFICIENCY 17 0.0014
246 FOETAL EXPOSURE TIMING UNSPECIFIED 1 0.0014
247 ANTIBODY TEST ABNORMAL 1 0.0014
248 ULCER 22 0.0014
249 ASPIRATION 15 0.0014
250 MOUTH HAEMORRHAGE 10 0.0014
251 INFUSION RELATED REACTION 90 0.0014
252 PNEUMONIA PNEUMOCOCCAL 2 0.0013
253 HYPERLIPIDAEMIA 16 0.0013
254 CORNEAL OEDEMA 3 0.0013
255 LUPUS-LIKE SYNDROME 12 0.0013
256 BRONCHITIS BACTERIAL 1 0.0013
257 CHROMATOPSIA 1 0.0013
258 ENTEROVESICAL FISTULA 1 0.0013
259 NORMAL NEWBORN 7 0.0013
260 BLOOD FIBRINOGEN INCREASED 1 0.0013
261 BLOOD DISORDER 10 0.0012
262 RASH VESICULAR 6 0.0012
263 IMMUNE-MEDIATED MYOCARDITIS 2 0.0012
264 CONTRAINDICATED PRODUCT ADMINISTERED 37 0.0012
265 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 1 0.0012
266 BOTULISM 1 0.0012
267 COLITIS ULCERATIVE 54 0.0012
268 RALES 7 0.0012
269 PRODUCT LABEL CONFUSION 7 0.0012
270 GENERAL PHYSICAL HEALTH DETERIORATION 138 0.0012
271 MYOCARDIAL FIBROSIS 1 0.0012
272 ENTEROBACTER INFECTION 2 0.0012
273 RECTAL HAEMORRHAGE 51 0.0012
274 CLOSTRIDIAL INFECTION 4 0.0012
275 OBSTRUCTIVE AIRWAYS DISORDER 13 0.0012
276 WOUND COMPLICATION 4 0.0012
277 LIVER FUNCTION TEST INCREASED 25 0.0012
278 DRUG INTOLERANCE 112 0.0012
279 BLISTER 65 0.0012
280 END STAGE RENAL DISEASE 21 0.0012
281 ACUTE CHEST SYNDROME 1 0.0011
282 ENTEROCUTANEOUS FISTULA 1 0.0011
283 DIVERTICULUM 8 0.0011
284 HAEMORRHAGIC DIATHESIS 4 0.0011
285 DRY MOUTH 91 0.0011
286 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 1 0.0011
287 RASH PAPULAR 25 0.0011
288 GOUT 20 0.0011
289 MUSCLE NECROSIS 1 0.0011
290 PNEUMONIA KLEBSIELLA 2 0.0011
291 RED BLOOD CELL SEDIMENTATION RATE INCREASED 12 0.0011
292 ENTEROCOLITIS INFECTIOUS 1 0.0011
293 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 77 0.0011
294 RENAL TUBULAR DISORDER 3 0.0011
295 BLOOD IRON INCREASED 2 0.0011
296 MICROANGIOPATHY 1 0.0011
297 HYPOPROTEINAEMIA 2 0.0011
298 DISCOLOURED VOMIT 1 0.0010
299 LOWER LIMB FRACTURE 20 0.0010
300 ANIMAL SCRATCH 1 0.0010
301 LUNG DISORDER 50 0.0010
302 GAIT INABILITY 34 0.0010
303 HYPOFIBRINOGENAEMIA 1 0.0010
304 LOW BIRTH WEIGHT BABY 8 0.0010
305 DEVICE RELATED SEPSIS 2 0.0010
306 MUCOSAL ULCERATION 1 0.0010
307 FALSE POSITIVE INVESTIGATION RESULT 1 0.0010
308 PULMONARY FIBROSIS 19 0.0010
309 EYE INJURY 3 0.0010
310 PRESCRIBED OVERDOSE 19 0.0010
311 BRAIN STEM INFARCTION 1 0.0010
312 INFUSION SITE DISCOMFORT 1 0.0010
313 PREMATURE BABY 29 0.0010
314 MICROCYTIC ANAEMIA 2 0.0010
315 BLOOD CREATININE DECREASED 3 0.0010
316 RHEUMATOID ARTHRITIS 107 0.0009
317 SCIATICA 15 0.0009
318 SLEEP DISORDER 66 0.0009
319 HAEMATOCHEZIA 51 0.0009
320 MOBILITY DECREASED 66 0.0009
321 SOMNOLENCE 184 0.0009
322 MATERNAL EXPOSURE DURING PREGNANCY 81 0.0009
323 CONGENITAL ANOMALY 7 0.0009
324 NEPHROSCLEROSIS 1 0.0009
325 MYOSITIS 8 0.0009
326 BRONCHIECTASIS 6 0.0009
327 SUSPECTED OFF LABEL USE 4 0.0009
328 TRICUSPID VALVE INCOMPETENCE 7 0.0009
329 HYPERSENSITIVITY PNEUMONITIS 1 0.0009
330 EAR PAIN 17 0.0009
331 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 2 0.0009
332 SINUS PAIN 2 0.0009
333 DEFAECATION URGENCY 6 0.0009
334 HYPORESPONSIVE TO STIMULI 1 0.0009
335 HEPATIC ENZYME INCREASED 58 0.0008
336 FINGER DEFORMITY 4 0.0008
337 BLOOD IMMUNOGLOBULIN G INCREASED 1 0.0008
338 CYTOPENIA 10 0.0008
339 COELIAC DISEASE 8 0.0008
340 BREATH SOUNDS ABNORMAL 4 0.0008
341 MALIGNANT MELANOMA IN SITU 1 0.0008
342 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 42 0.0008
343 MATERNAL EXPOSURE TIMING UNSPECIFIED 3 0.0008
344 EMPHYSEMA 8 0.0008
345 DRUG TOLERANCE 4 0.0008
346 INFUSION SITE IRRITATION 1 0.0008
347 ANAL INCONTINENCE 7 0.0008
348 EPIGASTRIC DISCOMFORT 3 0.0008
349 APLASTIC ANAEMIA 4 0.0008
350 HYPONATRAEMIA 43 0.0008
351 POLYARTHRITIS 4 0.0008
352 WALKING AID USER 5 0.0008
353 HERPES OPHTHALMIC 1 0.0008
354 GASTROENTERITIS NOROVIRUS 1 0.0008
355 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
356 CARDIAC FAILURE ACUTE 5 0.0007
357 HEPATIC ENCEPHALOPATHY 7 0.0007
358 CORNEAL OPACITY 1 0.0007
359 IMMUNOGLOBULINS DECREASED 1 0.0007
360 UNDERDOSE 53 0.0007
361 VITREOUS HAEMORRHAGE 2 0.0007
362 STEVENS-JOHNSON SYNDROME 16 0.0007
363 DEATH NEONATAL 1 0.0007
364 LUNG CONSOLIDATION 2 0.0007
365 INJURY 50 0.0007
366 CONFUSIONAL STATE 114 0.0007
367 PRESCRIBED UNDERDOSE 14 0.0007
368 OEDEMA 38 0.0007
369 HYSTERECTOMY 6 0.0007
370 BODY TEMPERATURE INCREASED 14 0.0007
371 MUSCULOSKELETAL STIFFNESS 60 0.0007
372 PARONYCHIA 3 0.0007
373 DYSPEPSIA 66 0.0007
374 ATYPICAL PNEUMONIA 2 0.0007
375 GENERAL SYMPTOM 5 0.0007
376 VASCULAR DEVICE INFECTION 3 0.0007
377 CALCULUS URINARY 1 0.0006
378 NEURITIS 1 0.0006
379 THERAPEUTIC PRODUCT EFFECT DECREASED 29 0.0006
380 ARTHRITIS INFECTIVE 3 0.0006
381 HEPATIC STEATOSIS 12 0.0006
382 ANAEMIA 122 0.0006
383 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
384 AFFECTIVE DISORDER 5 0.0006
385 IRIDOCYCLITIS 2 0.0006
386 INTESTINAL OPERATION 1 0.0006
387 INTERMITTENT CLAUDICATION 1 0.0006
388 HYPOAESTHESIA 94 0.0006
389 INCORRECT DOSE ADMINISTERED BY PRODUCT 1 0.0006
390 DISCOMFORT 38 0.0006
391 ENTEROCOCCAL INFECTION 3 0.0006
392 MICTURITION URGENCY 7 0.0006
393 INTESTINAL POLYP 1 0.0006
394 DELIRIUM 21 0.0006
395 TREATMENT FAILURE 50 0.0006
396 ABDOMINAL PAIN 140 0.0006
397 HYPOTONIA 6 0.0006
398 PULMONARY EMBOLISM 55 0.0006
399 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
400 THROMBOPHLEBITIS 2 0.0006
401 OEDEMA PERIPHERAL 69 0.0006
402 HISTOPLASMOSIS 1 0.0006
403 URTICARIA 94 0.0006
404 CYTOMEGALOVIRUS TEST POSITIVE 1 0.0006
405 IMMUNE-MEDIATED ENTEROCOLITIS 2 0.0005
406 RASH ERYTHEMATOUS 26 0.0005
407 CONDITION AGGRAVATED 165 0.0005
408 GAMMA-GLUTAMYLTRANSFERASE INCREASED 12 0.0005
409 FOOT DEFORMITY 6 0.0005
410 HIATUS HERNIA 7 0.0005
411 ON AND OFF PHENOMENON 3 0.0005
412 GRANULOCYTE COUNT DECREASED 1 0.0005
413 CYSTOID MACULAR OEDEMA 1 0.0005
414 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 9 0.0005
415 SPUTUM DISCOLOURED 5 0.0005
416 MYELOPATHY 1 0.0005
417 MIGRAINE 50 0.0005
418 LYMPHADENOPATHY MEDIASTINAL 1 0.0005
419 HYPOKALAEMIA 24 0.0005
420 NECK PAIN 29 0.0005
421 ARTERIAL THROMBOSIS 1 0.0005
422 MADAROSIS 6 0.0005
423 HYPERTENSION 109 0.0005
424 ABDOMINAL WALL HAEMATOMA 1 0.0005
425 DIABETES MELLITUS 39 0.0005
426 WOUND SECRETION 2 0.0005
427 THROMBOSIS 41 0.0005
428 HYPERAEMIA 1 0.0005
429 CELL DEATH 1 0.0005
430 SEPSIS 56 0.0005
431 OESOPHAGEAL CANDIDIASIS 2 0.0005
432 ABSCESS 8 0.0005
433 POLYNEUROPATHY 6 0.0005
434 SPINAL FRACTURE 10 0.0005
435 ABDOMINAL DISTENSION 52 0.0005
436 CARDIAC DISCOMFORT 1 0.0005
437 SPINAL FUSION SURGERY 2 0.0005
438 FOETAL EXPOSURE DURING PREGNANCY 40 0.0005
439 DECUBITUS ULCER 4 0.0005
440 CONSTIPATION 106 0.0005
441 CHOLANGITIS 3 0.0005
442 ILEUS 6 0.0005
443 LEUKOPENIA 24 0.0005
444 INTENTIONAL PRODUCT MISUSE 42 0.0005
445 SKIN LESION 13 0.0005
446 CANDIDA INFECTION 8 0.0005
447 JOINT DISLOCATION 5 0.0005
448 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
449 ANAEMIA MACROCYTIC 1 0.0005
450 ALOPECIA 92 0.0005
451 TENSION HEADACHE 2 0.0005
452 DEREALISATION 1 0.0005
453 LYMPHOCYTOSIS 1 0.0005
454 INFUSION SITE BRUISING 1 0.0005
455 HERPES SIMPLEX 3 0.0005
456 NASOPHARYNGITIS 85 0.0005
457 BLOOD CREATININE INCREASED 30 0.0005
458 CERVICAL DYSPLASIA 1 0.0005
459 PARAESTHESIA 72 0.0005
460 HENOCH-SCHONLEIN PURPURA 1 0.0005
461 CORNEAL DISORDER 1 0.0005
462 CYTOMEGALOVIRUS INFECTION REACTIVATION 2 0.0005
463 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
464 DRUG-INDUCED LIVER INJURY 14 0.0004
465 PAIN OF SKIN 12 0.0004
466 OCULAR DISCOMFORT 5 0.0004
467 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
468 METASTASES TO MENINGES 1 0.0004
469 APHTHOUS STOMATITIS 1 0.0004
470 HYPERTRANSAMINASAEMIA 3 0.0004
471 PERFORMANCE STATUS DECREASED 2 0.0004
472 THERMAL BURN 3 0.0004
473 FEBRILE NEUTROPENIA 28 0.0004
474 GASTROINTESTINAL TOXICITY 2 0.0004
475 ACUTE RESPIRATORY FAILURE 8 0.0004
476 OSTEOPOROSIS 17 0.0004
477 INTENTIONAL PRODUCT USE ISSUE 36 0.0004
478 PLEURAL EFFUSION 25 0.0004
479 BRONCHITIS CHRONIC 1 0.0004
480 ROAD TRAFFIC ACCIDENT 17 0.0004
481 STAPHYLOCOCCAL SEPSIS 2 0.0004
482 ORTHOSTATIC HYPOTENSION 7 0.0004
483 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
484 HEPATIC FAILURE 12 0.0004
485 PYREXIA 137 0.0004
486 DYSPHORIA 2 0.0004
487 HIP ARTHROPLASTY 6 0.0004
488 INCREASED BRONCHIAL SECRETION 1 0.0004
489 JOINT SWELLING 47 0.0004
490 PERIPHERAL SWELLING 59 0.0004
491 FOOD CRAVING 2 0.0004
492 BLOOD LACTATE DEHYDROGENASE INCREASED 6 0.0004
493 FULL BLOOD COUNT ABNORMAL 4 0.0004
494 SUDDEN DEATH 4 0.0004
495 NASAL DISORDER 1 0.0004
496 JOINT INJURY 8 0.0004
497 RHINITIS 3 0.0004
498 ABDOMINAL PAIN UPPER 76 0.0004
499 EAR CONGESTION 1 0.0004
500 UPPER RESPIRATORY TRACT INFECTION 17 0.0004
501 RESPIRATORY DISORDER 11 0.0004
502 SLEEP APNOEA SYNDROME 7 0.0004
503 FAECALOMA 2 0.0004
504 WHITE BLOOD CELL COUNT INCREASED 14 0.0004
505 CHOLESTASIS 7 0.0004
506 LIVER DISORDER 16 0.0004
507 TRANSAMINASES INCREASED 8 0.0004
508 HEART RATE ABNORMAL 2 0.0004
509 ANAL HAEMORRHAGE 1 0.0004
510 MEMORY IMPAIRMENT 49 0.0004
511 VENTRICULAR SEPTAL DEFECT 2 0.0003
512 SKIN HYPERPIGMENTATION 3 0.0003
513 INJECTION SITE REACTION 24 0.0003
514 HERPES VIRUS INFECTION 2 0.0003
515 MUSCLE STRAIN 3 0.0003
516 INTESTINAL OBSTRUCTION 13 0.0003
517 HAEMOTHORAX 1 0.0003
518 SKIN WARM 2 0.0003
519 HYPERKALAEMIA 12 0.0003
520 HAEMOGLOBIN DECREASED 35 0.0003
521 ASTHENIA 128 0.0003
522 ABDOMINAL DISCOMFORT 57 0.0003
523 ASPARTATE AMINOTRANSFERASE INCREASED 18 0.0003
524 ASTHMA 38 0.0003
525 PULMONARY MASS 5 0.0003
526 IMMUNODEFICIENCY 5 0.0003
527 GASTROINTESTINAL DISORDER 30 0.0003
528 GASTROINTESTINAL INFECTION 3 0.0003
529 PROTHROMBIN TIME PROLONGED 2 0.0003
530 METABOLIC ENCEPHALOPATHY 1 0.0003
531 LUNG ADENOCARCINOMA 1 0.0003
532 HYPERCAPNIA 1 0.0003
533 INGUINAL HERNIA 2 0.0003
534 DERMATITIS ACNEIFORM 2 0.0003
535 BRAIN DEATH 1 0.0003
536 HAEMOPTYSIS 9 0.0003
537 MULTIPLE-DRUG RESISTANCE 1 0.0003
538 PANCREATITIS 17 0.0003
539 EYELIDS PRURITUS 1 0.0003
540 PRODUCT USE IN UNAPPROVED INDICATION 79 0.0003
541 BLADDER PAIN 1 0.0003
542 BILE DUCT STONE 1 0.0003
543 HEPATITIS 8 0.0003
544 LIVER ABSCESS 1 0.0003
545 WEIGHT INCREASED 69 0.0003
546 MUSCULAR WEAKNESS 35 0.0003
547 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
548 BACK DISORDER 5 0.0003
549 JOINT STIFFNESS 8 0.0003
550 HYPOGAMMAGLOBULINAEMIA 2 0.0003
551 INFUSION SITE HAEMORRHAGE 1 0.0003
552 DISABILITY 6 0.0003
553 SARS-COV-2 TEST POSITIVE 4 0.0003
554 APPETITE DISORDER 2 0.0003
555 ADVERSE REACTION 4 0.0003
556 CYTOLYTIC HEPATITIS 1 0.0003
557 ACCIDENTAL OVERDOSE 11 0.0003
558 LYME DISEASE 1 0.0003
559 PREGNANCY 6 0.0003
560 ANXIETY DISORDER 1 0.0003
561 CYTOKINE RELEASE SYNDROME 6 0.0003
562 TOXIC SKIN ERUPTION 3 0.0003
563 CORONARY ARTERY DISEASE 9 0.0003
564 HEPATIC CYST 1 0.0003
565 CIRCULATORY COLLAPSE 5 0.0003
566 ERYTHEMA 60 0.0003
567 LYMPHOEDEMA 2 0.0003
568 ENCEPHALITIS 2 0.0003
569 GRANULOMA 1 0.0003
570 WEIGHT FLUCTUATION 3 0.0003
571 PNEUMONIA 92 0.0003
572 NEUROPATHY PERIPHERAL 27 0.0003
573 HAND FRACTURE 2 0.0003
574 MACULOPATHY 1 0.0003
575 FIBRIN D DIMER INCREASED 1 0.0003
576 WEIGHT DECREASED 77 0.0003
577 CUTANEOUS VASCULITIS 1 0.0003
578 EXPOSURE DURING PREGNANCY 17 0.0003
579 OFF LABEL USE 237 0.0003
580 FREEZING PHENOMENON 1 0.0003
581 THERAPY NON-RESPONDER 12 0.0003
582 BLOOD CALCIUM DECREASED 3 0.0003
583 DYSPNOEA EXERTIONAL 10 0.0003
584 VOMITING 124 0.0003
585 CLAVICLE FRACTURE 1 0.0003
586 TACHYCARDIA 23 0.0003
587 ATRIOVENTRICULAR BLOCK 2 0.0003
588 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
589 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
590 HYPOALBUMINAEMIA 2 0.0003
591 ORAL HERPES 5 0.0003
592 MUSCLE SPASMS 47 0.0003
593 SPLENOMEGALY 3 0.0003
594 CERVIX CARCINOMA 1 0.0003
595 NAIL DISCOLOURATION 1 0.0003
596 DYSPHAGIA 24 0.0003
597 SEPTIC SHOCK 11 0.0003
598 BLOOD ALBUMIN DECREASED 2 0.0003
599 ADVERSE EVENT 23 0.0002
600 BREAST CANCER 23 0.0002
601 BONE MARROW FAILURE 5 0.0002
602 AMNESIA 16 0.0002
603 GOITRE 1 0.0002
604 MUSCLE SPASTICITY 3 0.0002
605 CARDIOMEGALY 3 0.0002
606 ANAPHYLACTOID REACTION 1 0.0002
607 GASTROINTESTINAL PERFORATION 1 0.0002
608 ACCIDENTAL EXPOSURE 1 0.0002
609 FUNGAL INFECTION 8 0.0002
610 KNEE ARTHROPLASTY 5 0.0002
611 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
612 INTESTINAL STENOSIS 1 0.0002
613 HYPERSENSITIVITY 44 0.0002
614 PRODUCT QUALITY ISSUE 32 0.0002
615 NEUTROPENIA 32 0.0002
616 MALIGNANT NEOPLASM PROGRESSION 24 0.0002
617 SINUSITIS 24 0.0002
618 LUNG NEOPLASM 1 0.0002
619 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
620 ALCOHOLISM 1 0.0002
621 PANCYTOPENIA 13 0.0002
622 HORDEOLUM 1 0.0002
623 PYELONEPHRITIS 2 0.0002
624 ALANINE AMINOTRANSFERASE INCREASED 14 0.0002
625 GROIN PAIN 2 0.0002
626 PULMONARY CONGESTION 3 0.0002
627 TUMOUR LYSIS SYNDROME 2 0.0002
628 LUNG INFILTRATION 2 0.0002
629 LIGAMENT RUPTURE 1 0.0002
630 BLOOD CREATINE INCREASED 1 0.0002
631 EAR INFECTION 6 0.0002
632 OROPHARYNGEAL DISCOMFORT 2 0.0002
633 BLINDNESS 9 0.0002
634 IMMUNE THROMBOCYTOPENIA 1 0.0002
635 EAR DISORDER 1 0.0002
636 PNEUMONIA BACTERIAL 2 0.0002
637 PAIN 133 0.0002
638 GASTRITIS EROSIVE 1 0.0002
639 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 5 0.0002
640 ILL-DEFINED DISORDER 13 0.0002
641 ARTERIOSCLEROSIS 2 0.0002
642 HEPATOCELLULAR INJURY 3 0.0002
643 CARDIAC TAMPONADE 1 0.0002
644 ENDOMETRIOSIS 1 0.0002
645 SUBDURAL HAEMATOMA 3 0.0002
646 FAECAL INCONTINENCE 1 0.0002
647 PRESYNCOPE 5 0.0002
648 ATRIAL FIBRILLATION 20 0.0002
649 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
650 INCORRECT DOSAGE ADMINISTERED 1 0.0002
651 HEPATOMEGALY 2 0.0002
652 LABORATORY TEST ABNORMAL 6 0.0002
653 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
654 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
655 NEOPLASM PROGRESSION 7 0.0002
656 HEPATIC ENZYME ABNORMAL 1 0.0002
657 HYPERAMMONAEMIA 1 0.0002
658 FLUID INTAKE REDUCED 1 0.0002
659 DIARRHOEA 129 0.0002
660 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
661 ERYSIPELAS 1 0.0002
662 KLEBSIELLA INFECTION 1 0.0002
663 EYELID PTOSIS 2 0.0002
664 BLOOD PRESSURE DECREASED 13 0.0002
665 FEMORAL NECK FRACTURE 1 0.0002
666 ENDOCARDITIS 1 0.0002
667 DEHYDRATION 26 0.0002
668 CEREBRAL ISCHAEMIA 1 0.0002
669 TENDONITIS 3 0.0002
670 UNRESPONSIVE TO STIMULI 5 0.0002
671 LUNG INFECTION 3 0.0002
672 HAEMATOMA 5 0.0002
673 TENDERNESS 2 0.0002
674 PETECHIAE 2 0.0002
675 MUCOSAL INFLAMMATION 5 0.0002
676 NAUSEA 150 0.0002
677 ARTHRALGIA 78 0.0002
678 CONTUSION 18 0.0002
679 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
680 ANAL FISSURE 1 0.0002
681 RASH 81 0.0002
682 HIP SURGERY 1 0.0002
683 SKIN LACERATION 2 0.0002
684 DYSPNOEA 104 0.0002
685 PNEUMONITIS 5 0.0002
686 JAW DISORDER 1 0.0002
687 STAPHYLOCOCCAL INFECTION 6 0.0002
688 DRY EYE 9 0.0002
689 MEDICATION ERROR 10 0.0002
690 AGGRESSION 9 0.0002
691 LOSS OF CONSCIOUSNESS 23 0.0002
692 INTRACRANIAL PRESSURE INCREASED 1 0.0002
693 MALNUTRITION 2 0.0002
694 EYE INFECTION 2 0.0002
695 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
696 BRONCHITIS 13 0.0002
697 GRANULOCYTOPENIA 1 0.0002
698 FATIGUE 134 0.0002
699 DEPRESSION 39 0.0002
700 HYPERTRIGLYCERIDAEMIA 1 0.0002
701 CHILLS 20 0.0002
702 HYPOXIA 6 0.0002
703 THROMBOCYTOPENIA 19 0.0002
704 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1 0.0002
705 CATARACT OPERATION 1 0.0002
706 DISEASE RECURRENCE 8 0.0002
707 CHOLECYSTITIS 2 0.0002
708 CEREBRAL HAEMORRHAGE 6 0.0002
709 ADVERSE DRUG REACTION 15 0.0002
710 ENDOPHTHALMITIS 1 0.0002
711 LEUKOCYTOSIS 3 0.0002
712 INTERSTITIAL LUNG DISEASE 8 0.0002
713 RESPIRATORY FAILURE 12 0.0002
714 RESTLESSNESS 6 0.0002
715 HYPERCALCAEMIA 2 0.0002
716 MALAISE 71 0.0002
717 THINKING ABNORMAL 3 0.0002
718 DISEASE PROGRESSION 19 0.0002
719 NERVOUS SYSTEM DISORDER 5 0.0002
720 NASAL DRYNESS 1 0.0002
721 DECREASED APPETITE 37 0.0002
722 CARDIOVASCULAR DISORDER 4 0.0002
723 ACUTE KIDNEY INJURY 24 0.0002
724 HAEMOGLOBIN ABNORMAL 1 0.0002
725 INCOHERENT 1 0.0002
726 ASPERGILLUS INFECTION 1 0.0002
727 INFECTION 22 0.0002
728 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
729 MENINGITIS 1 0.0001
730 PRODUCT USE ISSUE 28 0.0001
731 HEADACHE 93 0.0001
732 BLOOD BILIRUBIN INCREASED 4 0.0001
733 RASH PRURITIC 8 0.0001
734 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
735 NEUTROPHIL COUNT DECREASED 6 0.0001
736 CROHN'S DISEASE 1 0.0001
737 RIB FRACTURE 3 0.0001
738 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7 0.0001
739 OXYGEN SATURATION DECREASED 8 0.0001
740 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
741 SKIN REACTION 2 0.0001
742 BLINDNESS UNILATERAL 2 0.0001
743 NEUTROPENIC SEPSIS 1 0.0001
744 ANGINA PECTORIS 4 0.0001
745 DEEP VEIN THROMBOSIS 9 0.0001
746 DERMATITIS BULLOUS 1 0.0001
747 HYPERTHYROIDISM 2 0.0001
748 HYPOKINESIA 2 0.0001
749 FLUID RETENTION 7 0.0001
750 VISUAL IMPAIRMENT 17 0.0001
751 CARDIAC FAILURE 11 0.0001
752 DIZZINESS 68 0.0001
753 RASH MACULO-PAPULAR 3 0.0001
754 FEELING DRUNK 1 0.0001
755 ORAL PAIN 3 0.0001
756 HEPATIC FUNCTION ABNORMAL 5 0.0001
757 ECZEMA 7 0.0001
758 HYPOAESTHESIA ORAL 2 0.0001
759 BRADYCARDIA 7 0.0001
760 THERAPEUTIC RESPONSE DECREASED 8 0.0001
761 HEPATOCELLULAR CARCINOMA 1 0.0001
762 HYPERTHERMIA 1 0.0001
763 ACIDOSIS 1 0.0001
764 LIPASE INCREASED 1 0.0001
765 FEELING HOT 8 0.0001
766 DISSOCIATION 1 0.0001
767 PERICARDIAL EFFUSION 3 0.0001
768 EJECTION FRACTION DECREASED 2 0.0001
769 APNOEA 1 0.0001
770 ACUTE MYELOID LEUKAEMIA 2 0.0001
771 BASAL CELL CARCINOMA 2 0.0001
772 RENAL FAILURE 17 0.0001
773 ARTHRITIS 10 0.0001
774 ATRIAL FLUTTER 1 0.0001
775 HYPOTHYROIDISM 4 0.0001
776 CEREBRAL INFARCTION 3 0.0001
777 ABNORMAL FAECES 1 0.0001
778 ACUTE CORONARY SYNDROME 1 0.0001
779 VISUAL ACUITY REDUCED 4 0.0001
780 HEMIPLEGIA 1 0.0001
781 GAIT DISTURBANCE 23 0.0001
782 BLOOD UREA INCREASED 2 0.0001
783 PAIN IN EXTREMITY 35 0.0001
784 FACIAL PARALYSIS 1 0.0001
785 HAEMATURIA 4 0.0001
786 MYOPATHY 1 0.0001
787 MULTI-ORGAN FAILURE 2 0.0001
788 DIPLOPIA 3 0.0001
789 RESPIRATORY TRACT INFECTION 3 0.0001
790 VERTIGO 7 0.0001
791 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
792 DRUG ERUPTION 2 0.0001
793 FACIAL PAIN 1 0.0001
794 THIRST 2 0.0001
795 HAEMOLYTIC ANAEMIA 1 0.0001
796 GRAND MAL CONVULSION 1 0.0001
797 CONJUNCTIVITIS 2 0.0001
798 AGRANULOCYTOSIS 2 0.0001
799 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
800 EYE PAIN 6 0.0001
801 PHOTOPHOBIA 2 0.0001
802 URINARY TRACT INFECTION 18 0.0001
803 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 19 0.0001
804 GASTRIC ULCER 2 0.0001
805 EYE INFLAMMATION 1 0.0001
806 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
807 CHEST PAIN 19 0.0001
808 PLASMA CELL MYELOMA 4 0.0001
809 CHOKING 2 0.0001
810 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
811 DRUG INEFFECTIVE 134 0.0001
812 PRURITUS 39 0.0001
813 HAEMATOCRIT DECREASED 2 0.0001
814 SUICIDE ATTEMPT 6 0.0001
815 MOTOR DYSFUNCTION 1 0.0001
816 NEUTROPHIL COUNT INCREASED 1 0.0001
817 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
818 PERITONITIS 2 0.0001
819 HYPERBILIRUBINAEMIA 1 0.0001
820 RENAL IMPAIRMENT 8 0.0001
821 INCONTINENCE 1 0.0001
822 BREAST PAIN 1 0.0001
823 PSORIASIS 12 0.0001
824 TREMOR 15 0.0001
825 SKIN DISORDER 3 0.0001
826 HEPATOTOXICITY 2 0.0001
827 INFLUENZA 10 0.0001
828 SNEEZING 2 0.0001
829 INTESTINAL PERFORATION 1 0.0001
830 OVERDOSE 19 0.0001
831 CHEST DISCOMFORT 9 0.0001
832 DERMATITIS CONTACT 1 0.0001
833 SHOCK 2 0.0001
834 EYE IRRITATION 5 0.0001
835 METASTASES TO LUNG 1 0.0001
836 RASH MACULAR 3 0.0001
837 BLOOD PRESSURE INCREASED 13 0.0001
838 LYMPHADENOPATHY 3 0.0001
839 COVID-19 PNEUMONIA 1 0.0001
840 ANXIETY 24 0.0001
841 OCULAR HYPERAEMIA 4 0.0001
842 BLOOD IRON DECREASED 1 0.0001
843 ATAXIA 1 0.0001
844 MUSCLE RIGIDITY 1 0.0001
845 FALL 27 0.0001
846 DERMATITIS ALLERGIC 1 0.0001
847 HAEMATEMESIS 2 0.0001
848 HEPATIC CYTOLYSIS 1 0.0001
849 INTRAOCULAR PRESSURE INCREASED 1 0.0001
850 INFUSION SITE PAIN 1 0.0001
851 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
852 GASTRITIS 2 0.0001
853 ANKYLOSING SPONDYLITIS 1 0.0001
854 INSOMNIA 20 0.0001
855 PLATELET COUNT DECREASED 8 0.0001
856 LIMB INJURY 2 0.0001
857 INFLUENZA LIKE ILLNESS 6 0.0001
858 CARDIAC ARREST 6 0.0001
859 APHONIA 1 0.0001
860 HOSPITALISATION 11 0.0001
861 MASS 1 0.0001
862 HEART RATE INCREASED 7 0.0001
863 DIALYSIS 1 0.0001
864 HYPOTENSION 14 0.0001
865 HYPOACUSIS 3 0.0001
866 IMPAIRED QUALITY OF LIFE 1 0.0001
867 GASTROENTERITIS 1 0.0001
868 CARDIOMYOPATHY 1 0.0001
869 THROAT IRRITATION 3 0.0001
870 APHASIA 2 0.0001
871 DEVICE RELATED INFECTION 1 0.0001
872 ANKLE FRACTURE 1 0.0001
873 RENAL DISORDER 3 0.0001
874 DELUSION 1 0.0001
875 COUGH 18 0.0001
876 BRAIN FOG 1 0.0001
877 CYANOSIS 1 0.0001
878 ARRHYTHMIA 3 0.0001
879 BLOOD POTASSIUM INCREASED 1 0.0001
880 CHOLELITHIASIS 2 0.0001
881 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
882 VIRAL INFECTION 2 0.0001
883 COAGULOPATHY 1 0.0001
884 SYNCOPE 6 0.0001
885 CELLULITIS 3 0.0001
886 MYALGIA 10 0.0001
887 MUSCULOSKELETAL DISCOMFORT 1 0.0001
888 SPEECH DISORDER 3 0.0001
889 COLD SWEAT 1 0.0001
890 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
891 LYMPHOCYTE COUNT DECREASED 1 0.0001
892 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
893 WHITE BLOOD CELL COUNT DECREASED 6 0.0001
894 HYPERGLYCAEMIA 2 0.0001
895 PANIC ATTACK 2 0.0001
896 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
897 ANAPHYLACTIC REACTION 3 0.0001
898 OROPHARYNGEAL PAIN 5 0.0001
899 EPISTAXIS 4 0.0001
900 CARDIAC DISORDER 5 0.0001
901 HALLUCINATION 4 0.0001
902 FLATULENCE 3 0.0001
903 BLOOD URINE PRESENT 1 0.0001
904 SEIZURE 6 0.0001
905 GLAUCOMA 1 0.0001
906 HERNIA 1 0.0001
907 ERUCTATION 1 0.0001
908 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
909 DEATH 44 0.0001
910 VISION BLURRED 7 0.0001
911 INTENTIONAL SELF-INJURY 1 0.0000
912 FEEDING DISORDER 1 0.0000
913 DYSKINESIA 2 0.0000
914 RHABDOMYOLYSIS 2 0.0000
915 DERMATITIS 1 0.0000
916 MOUTH ULCERATION 1 0.0000
917 RENAL FAILURE ACUTE 2 0.0000
918 EATING DISORDER 1 0.0000
919 RHINORRHOEA 3 0.0000
920 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
921 SWELLING FACE 3 0.0000
922 DEVICE DISLOCATION 2 0.0000
923 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
924 COVID-19 8 0.0000
925 MELAENA 1 0.0000
926 DRY SKIN 6 0.0000
927 DRUG INTERACTION 7 0.0000
928 ENCEPHALOPATHY 1 0.0000
929 UNEVALUABLE EVENT 3 0.0000
930 HYPOPHAGIA 1 0.0000
931 DRUG RESISTANCE 1 0.0000
932 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
933 ANAPHYLACTIC SHOCK 1 0.0000
934 BACK PAIN 9 0.0000
935 DEAFNESS 1 0.0000
936 INJECTION SITE BRUISING 3 0.0000
937 JAUNDICE 1 0.0000
938 DISTURBANCE IN ATTENTION 2 0.0000
939 TREATMENT NONCOMPLIANCE 2 0.0000
940 FEELING COLD 1 0.0000
941 DEMENTIA 1 0.0000
942 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
943 LIVER FUNCTION TEST ABNORMAL 1 0.0000
944 DYSPHONIA 2 0.0000
945 PRODUCT DOSE OMISSION ISSUE 10 0.0000
946 ACUTE MYOCARDIAL INFARCTION 1 0.0000
947 LACRIMATION INCREASED 1 0.0000
948 CYSTITIS 1 0.0000
949 INTENTIONAL OVERDOSE 2 0.0000
950 MOVEMENT DISORDER 1 0.0000
951 HIP FRACTURE 1 0.0000
952 LIP SWELLING 1 0.0000
953 EYE PRURITUS 1 0.0000
954 FEELING ABNORMAL 7 0.0000
955 ILLNESS 3 0.0000
956 HEART RATE DECREASED 1 0.0000
957 NO ADVERSE EVENT 5 0.0000
958 DYSURIA 1 0.0000
959 DYSGEUSIA 2 0.0000
960 DYSARTHRIA 1 0.0000
961 CHRONIC KIDNEY DISEASE 2 0.0000
962 PALPITATIONS 3 0.0000
963 TOXICITY TO VARIOUS AGENTS 4 0.0000
964 BALANCE DISORDER 2 0.0000
965 ANGIOEDEMA 1 0.0000
966 SUICIDAL IDEATION 2 0.0000
967 NEPHROLITHIASIS 1 0.0000
968 HYPOGLYCAEMIA 1 0.0000
969 HAEMORRHAGE 2 0.0000
970 DEPRESSED MOOD 1 0.0000
971 CEREBROVASCULAR ACCIDENT 3 0.0000
972 HERPES ZOSTER 1 0.0000
973 BONE PAIN 1 0.0000
974 INJECTION SITE ERYTHEMA 2 0.0000
975 NEOPLASM MALIGNANT 1 0.0000
976 INJECTION SITE PRURITUS 1 0.0000
977 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
978 BURNING SENSATION 1 0.0000
979 ACNE 1 0.0000
980 INCORRECT DOSE ADMINISTERED 3 0.0000
981 INJECTION SITE SWELLING 1 0.0000
982 CARDIAC FAILURE CONGESTIVE 1 0.0000
983 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
984 DEVICE ISSUE 1 0.0000
985 BLOOD GLUCOSE INCREASED 2 0.0000
986 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
987 FLUSHING 1 0.0000
988 HYPERHIDROSIS 1 0.0000
989 INJECTION SITE PAIN 2 0.0000
990 DRUG DEPENDENCE 1 0.0000